Loading...
Treatment of scleromyxedema with lenalidomide, bortezomib and dexamethasone: A case report and review of the literature
Scleromyxedema is a rare and progressive disease that currently has no standard treatment. Triplet therapy with lenalidomide, bortezomib, and dexamethasone can be an effective therapy for scleromyxedema, especially in patients with refractory or relapsed disease.
Na minha lista:
| Udgivet i: | Clin Case Rep |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7752349/ https://ncbi.nlm.nih.gov/pubmed/33363876 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.3302 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|